TheraCryf (LSE:TCF) Other Stockholders Equity : £2.29 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is TheraCryf Other Stockholders Equity?

TheraCryf's Other Stockholders Equity for the quarter that ended in Sep. 2024 was £2.29 Mil.

TheraCryf's quarterly Other Stockholders Equity increased from Sep. 2023 (£2.63 Mil) to Mar. 2024 (£2.70 Mil) but then declined from Mar. 2024 (£2.70 Mil) to Sep. 2024 (£2.29 Mil).

TheraCryf's annual Other Stockholders Equity increased from Mar. 2022 (£2.56 Mil) to Mar. 2023 (£2.58 Mil) and increased from Mar. 2023 (£2.58 Mil) to Mar. 2024 (£2.70 Mil).

TheraCryf Other Stockholders Equity Historical Data

The historical data trend for TheraCryf's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Other Stockholders Equity Chart

TheraCryf Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Stockholders Equity

Get a 7-Day Free Trial

3.96

2.43

2.56

2.58

2.70

TheraCryf Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															2.62	2.58	2.63	2.70	2.29

TheraCryf Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

TheraCryf Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TheraCryf's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TheraCryf Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG

Website

https://www.evgen.com

TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.